Heroin Drug Needle in Syringe with Cocaine in Bag

Aegis Selected as UnitedHealthcare Preferred Lab Network Provider

NASHVILLE, Tenn., July 1, 2023 – Aegis is pleased to announce that following a rigorous review process, it will continue to participate as a UnitedHealthcare Preferred Lab Network (PLN) provider for 2023-2024.

The Preferred Lab Network consists of currently contracted independent, freestanding laboratory care providers that have met higher standards for access, cost, data, quality, and service.

For over 30 years, Aegis has been a national leader in healthcare and forensic laboratory sciences. Aegis provides clear, reliable and actionable information on patients’ prescription and non-prescription substance use to help healthcare providers deliver the best care.

Aegis offers a flexible and customizable testing menu of over 320 drugs/metabolites which includes the most comprehensive novel psychoactive and designer drug testing services to stay on the forefront of drug use trends throughout the United States.

“Aegis’s commitment to quality and excellence aligns with the UnitedHealthcare Triple Aim Focus of improving healthcare affordability, outcomes, and the patient experience,” said Nick Hobbs, Vice President of Managed Care at Aegis Sciences Corporation. “Being designated a UnitedHealthcare PLN reflects Aegis’s commitment to clinical excellence.”

Read UnitedHealthcare’s announcent:
The July 1 Preferred Lab Network list is available